Ads
related to: johnson & johnson- Latest news
See the latest news from J&J.
Company updates and more.
- Our leadership team
Meet the J&J Executive Committee
& our Board of Directors.
- The J&J Credo
Putting the needs of the
people we serve first.
- Discover J&J
Learn about our strength
in healthcare innovation.
- Latest news
Search results
Johnson & Johnson (JNJ) receives a Buy rating from HSBC Securities – Knox Daily
Knox Daily· 1 day agoJohnson & Johnson’s recently made public that its EVP, Global Corp Affairs Broadhurst Vanessa unloaded Company’s shares for reported $1.44 million on Mar ...
J&J-backed startup Rapport files for US IPO
Reuters· 4 days agoBiopharmaceutical company Rapport Therapeutics, backed by the venture capital arm of Johnson & Johnson , filed for an initial public offering in the...
Marathon Capital Management Has $4.48 Million Holdings in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 2 days agoMarathon Capital Management grew its stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 0.6% during the fourth quarter, according to the company ...
J&J study shows 25% of pulsed field ablation procedures performed with zero X-ray guidance
FierceBiotech· 17 hours agoJohnson & Johnson MedTech’s Biosense Webster division presented new clinical data backing up its...
Johnson & Johnson Insiders Sell US$6.8m Of Stock, Possibly Signalling Caution
Simply Wall St. via Yahoo Finance· 4 days agoThe fact that multiple Johnson & Johnson (NYSE:JNJ) insiders offloaded a considerable amount of...
NBC Securities Inc. Trims Stake in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 7 days agoNBC Securities Inc. lessened its holdings in Johnson & Johnson (NYSE:JNJ – Free Report) by 6.8% during the fourth quarter, according to its most recent ...
Johnson & Johnson (NYSE:JNJ) Shares Sold by Johnson Investment Counsel Inc.
ETF DAILY NEWS· 7 days agoJohnson Investment Counsel Inc. cut its holdings in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 12.4% in the 4th quarter, according to the company ...
Johnson & Johnson To Acquire Early-Stage Eczema Treatment Developer Proteologix For $850M
Benzinga via AOL· 6 days agoThursday, Johnson & Johnson (NYSE:JNJ) agreed to acquire Proteologix Inc., a privately held...
Johnson & Johnson to acquire Proteologix for $850 million By Investing.com
Investing.com· 6 days agoJohnson & Johnson (NYSE: JNJ) announced it will acquire biotechnology firm Proteologix, Inc. for...
Johnson & Johnson, Citing 'Eye-Opening' Emails, Moves to Subpoena Beasley Allen | New Jersey Law...
Law.com· 4 days agoJohnson & Johnson lodged a new attack against Beasley Allen, asking a federal judge to order...
Ad
related to: johnson & johnson
